As of 2024-12-11, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (100.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.03 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -2595.5%.
The range of the Relative Valuation is (93.93) - (87.62) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | (93.93) - (87.62) | (100.44) |
| Upside | -2433.8% - -2276.9% | -2595.5% |
| Date | P/E |
| 2024-12-06 | -0.96 |
| 2024-12-05 | -0.93 |
| 2024-12-04 | -0.95 |
| 2024-12-03 | -0.97 |
| 2024-12-02 | -1.01 |
| 2024-11-29 | -1.00 |
| 2024-11-27 | -0.97 |
| 2024-11-26 | -0.93 |
| 2024-11-25 | -0.95 |
| 2024-11-22 | -0.94 |
| 2024-11-21 | -0.94 |
| 2024-11-20 | -0.92 |
| 2024-11-19 | -0.93 |
| 2024-11-18 | -0.94 |
| 2024-11-15 | -0.99 |
| 2024-11-14 | -1.10 |
| 2024-11-13 | -1.14 |
| 2024-11-12 | -1.19 |
| 2024-11-11 | -1.23 |
| 2024-11-08 | -1.28 |
| 2024-11-07 | -1.28 |
| 2024-11-06 | -1.31 |
| 2024-11-05 | -1.30 |
| 2024-11-04 | -1.28 |
| 2024-11-01 | -1.26 |
| 2024-10-31 | -1.22 |
| 2024-10-30 | -1.29 |
| 2024-10-29 | -1.29 |
| 2024-10-28 | -1.31 |
| 2024-10-25 | -1.29 |
| 2024-10-24 | -1.31 |
| 2024-10-23 | -1.32 |
| 2024-10-22 | -1.32 |
| 2024-10-21 | -1.33 |
| 2024-10-18 | -1.30 |
| 2024-10-17 | -1.31 |
| 2024-10-16 | -1.33 |
| 2024-10-15 | -1.29 |
| 2024-10-14 | -1.32 |
| 2024-10-11 | -1.33 |
| 2024-10-10 | -1.25 |
| 2024-10-09 | -1.27 |
| 2024-10-08 | -1.32 |
| 2024-10-07 | -1.23 |
| 2024-10-04 | -1.28 |
| 2024-10-03 | -1.31 |
| 2024-10-02 | -1.31 |
| 2024-10-01 | -1.30 |
| 2024-09-30 | -1.34 |
| 2024-09-27 | -1.35 |